| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3945132 | Gynecologic Oncology | 2012 | 5 Pages |
Abstract
⺠This is the first prospective multi-institutional study to evaluate paclitaxel plus carboplatin combination for metastatic or recurrent cervical cancer. ⺠This regimen provided a promising response rate of 59%, median PFS of 5.3 months, and median OS of 9.6 months. ⺠Toxicities of this regimen were well-tolerated and feasible regimen in outpatient setting.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Ryo Kitagawa, Noriyuki Katsumata, Masashi Ando, Chikako Shimizu, Yasuhiro Fujiwara, Hiroyuki Yoshikawa, Toyomi Satoh, Toru Nakanishi, Kimio Ushijima, Toshiharu Kamura,